BSE filing, NSE: SAPTAK. Summary written from the filing by ALFA Finder's alert engine.
Saptak Chem And Business Ltd: key numbers
- Share price
- ₹21.85
- Market cap
- ₹6.71 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.30 Cr
- P/E (TTM)
- -22.5×Sector 36.4×
- Promoter holding
- 4.39%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Saptak Chem And Business Ltd
All →Saptak Chem And Business Q2 FY27 Results: Net Profit ₹0 Cr
Saptak Chem And Business Ltd reported net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Saptak Chem And Business Other Announcement
The company filed the quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming dematerialization details for the period ended September 30, 2026.
Saptak Chem And Business Annual General Meeting
Saptak Chem and Business Limited held its 47th Annual General Meeting on August 29, 2026, via video conferencing. Shareholders transacted ordinary and special business items during the meeting.
Saptak Chem And Business Annual General Meeting
Saptak Chem and Business Limited issued a corrigendum to its 47th AGM notice, rescheduling the meeting to August 29, 2026, and updating director appointment dates.
Saptak Chem And Business Annual Report
Saptak Chem and Business Limited has submitted its 47th Annual Report for the financial year 2025-26 to the BSE. The report is now available for shareholder reference.
Saptak Chem And Business Annual General Meeting
Saptak Chem and Business Limited issued notice for its 47th Annual General Meeting, scheduled for August 28, 2026, via video conferencing.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.